GMCM
GILD icon

Gruber & McBaine Capital Management’s Gilead Sciences GILD Stock Holding History

Gruber & McBaine Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-25,000
Closed -$1.77M – 208
2014
Q1 		$1.77M Buy
+25,000
New +$1.96M 0.46% 70

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Gruber & McBaine Capital Management's GILD Position: Q2 2014 in Review

Gruber & McBaine Capital Management sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 25,000 shares — an estimated $1.77M sold.

Gruber & McBaine Capital Management first reported a position in GILD in Q1 2014 and held it in 1 quarter. The position peaked at $1.77M in Q1 2014. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Gruber & McBaine Capital Management reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
  • Gruber & McBaine Capital Management sold 25,000 Gilead Sciences shares in Q2 2014, an estimated $1.77M.
  • Gruber & McBaine Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 1 quarter.
  • Gruber & McBaine Capital Management's Gilead Sciences position peaked at $1.77M in Q1 2014.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Gruber & McBaine Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.